Scarica l'app Stockscreener
0.9393
19.03%
-0.2207
Dopo l'orario di chiusura:
.96
0.0207
+2.20%
Invivyd Inc Borsa (IVVD) Ultime notizie
Why Invivyd, Inc. (IVVD) is Skyrocketing So Far in 2025 - Yahoo Finance
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey
The Zacks Analyst Blog Highlights INVIVYD, 21Vianet, FuboTV, Noodles and Digital Turbine - Yahoo Finance
Invivyd (NASDAQ:IVVD) Receives “Buy” Rating from D. Boral Capital - Defense World
Invivyd (NASDAQ:IVVD) Given “Buy” Rating at HC Wainwright - Defense World
FDA declines Invivyd’s COVID-19 treatment EUA expansion By Investing.com - Investing.com Nigeria
IVVD Stock: More Upside For Invivyd Inc (NASDAQ: IVVD)? - Marketing Sentinel
FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients - Benzinga
Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday - TradingView
Invivyd says FDA declines request to expand existing EUA of PEMGARDA - TipRanks
Sector Update: Health Care - TradingView
5 Stocks That More Than Doubled Halfway Through Q1 - Zacks Investment Research
Invivyd's Request to Treat Covid-19 Patients With Pemgarda Rejected by US FDA -February 24, 2025 at 08:04 am EST - Marketscreener.com
FDA declines Invivyd’s COVID-19 treatment EUA expansion - Investing.com
FDA declines Invivyd's COVID-19 treatment EUA expansion By Investing.com - Investing.com South Africa
FDA Declined Invivyd's Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Chang - The Manila Times
Can PEMGARDA Still Succeed? FDA Blocks COVID Treatment Expansion but Keeps Prevention Approval - StockTitan
Invivyd news ‘disappointing’ but not in model, says H.C. Wainwright - TipRanks
Invivyd, Inc. (NASDAQ:IVVD) Short Interest Up 5.2% in January - Armenian Reporter
Why Invivyd, Inc. (IVVD) Is Soaring This Year So Far - MSN
10 Micro and Small-Cap Firms Drive Year-to-Date Gains - Insider Monkey
Invivyd, Inc. (NASDAQ:IVVD) Sees Significant Growth in Short Interest - MarketBeat
Invivyd Inc (NASDAQ: IVVD) Stock Forecast: Bearish Views Expect -505.1 Percent Drop In 2025 - Stocks Register
Holdings of Invivyd Inc (IVVD) are aligned with the stars - SETE News
How does IVVD’s price to cash per share ratio compare in the market? - US Post News
Stock Traders Purchase High Volume of Invivyd Call Options (NASDAQ:IVVD) - MarketBeat
IVVD’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Invivyd Inc’s (IVVD) Stock: A Week-by-Week Analysis - The News Heater
Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 - The Manila Times
FY2024 Earnings Estimate for Invivyd Issued By HC Wainwright - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Invivyd (NASDAQ:IVVD) - MarketBeat
Invivyd Inc [IVVD] stock for 46,098 USD was sold by MCGUIRE TERRANCE - Knox Daily
Exploring High Growth Tech Stocks in the United States - Simply Wall St
Following A 407.69% Weekly Incline, Is It Still A Buy For Invivyd Inc (NASDAQ: IVVD)? - Marketing Sentinel
HC Wainwright Issues Negative Estimate for Invivyd Earnings - Defense World
Top Small Cap Stocks Worth WatchingFebruary 03rd - MarketBeat
This Penny Stock Just Doubled on Clinical Trial Results. Analysts Think It Can Surge 266% From Here. - MSN
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Invivyd (IVVD) Stock Rises Following Strategic Partnership - Stocks Telegraph
Invivyd tweaks COVID prophylactic playbook, teaming with NFL coach Jim Harbaugh for awareness drive - FiercePharma
Invivyd (NASDAQ:IVVD) Earns “Buy” Rating from HC Wainwright - Defense World
Los Angeles Chargers coach Jim Harbaugh reminds people COVID isn’t a cold - MM+M Online
Brokers Offer Predictions for Invivyd FY2029 Earnings - Defense World
Invivyd Inc Reports Q4 2024 Revenue of $13.8 Million, Slightly B - GuruFocus.com
H.C. Wainwright maintains Buy rating on Invivyd stock at $10 target - MSN
(IVVD)Analyzing Invivyd's Short Interest - Benzinga
Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold - The Manila Times
Football Legend Jim Harbaugh Joins Forces with Invivyd as COVID Deaths Surge: One American Lost Every 9 Minutes - StockTitan
Analysts’ Revisions Show Improving Sentiment For Invivyd Inc (NASDAQ: IVVD) - Stocks Register
D. Boral Capital Reiterates “Buy” Rating for Invivyd (NASDAQ:IVVD) - Defense World
I See The Bull Case For Invivyd, But I’m Not Married To It (NASDAQ:IVVD) - Seeking Alpha
Invivyd Tracks SARS-CoV-2 Evolution, Prepares for Future Variants - Contagionlive.com
A Guide To The Risks Of Investing In Invivyd Inc (IVVD) - Knox Daily
Invivyd’s Promising Developments in COVID-19 Therapeutics Support Buy Rating - TipRanks
HC Wainwright Reiterates "Buy" Rating for Invivyd (NASDAQ:IVVD) - MarketBeat
It makes sense and dollars to buy Invivyd Inc (IVVD) stock - SETE News
Invivyd Shares Soar Premarket After Tripling Monday Following Initial Results From COVID-19 Vaccination Alternative - Marketscreener.com
6.45%
1.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):